Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Lymphoid 7Other 3Thoracic 1Other hematologic neoplasm 1Gynecologic 1Genitourinary 1Classical hematology 1

Conditions

Lung Neoplasms 1371Carcinoma, Non-Small-Cell Lung 1080Breast Neoplasms 183Neoplasms 145Small Cell Lung Carcinoma 137Colorectal Neoplasms 104Adenocarcinoma of Lung 87Melanoma 84Prostatic Neoplasms 80Pancreatic Neoplasms 79Esophageal Neoplasms 70Head and Neck Neoplasms 69Ovarian Neoplasms 67Colonic Neoplasms 67Stomach Neoplasms 63Urinary Bladder Neoplasms 49Neoplasm Metastasis 49Disease 49Mesothelioma 44Liver Neoplasms 44Pulmonary Disease, Chronic Obstructive 42Mesothelioma, Malignant 42Brain Neoplasms 37Lung Diseases 36Carcinoma, Renal Cell 35Uterine Cervical Neoplasms 34Pleural Effusion, Malignant 34Kidney Neoplasms 33NSCLC 31Carcinoma 28

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Dementia × Thoracic × Clear all
NCT03987633 2025-03-10

EMPOWER

Future Genetics Limited

Recruiting
200,000 enrolled
GenitourinaryOtherThoracic

Ischemic Stroke, Arthritis, Rheumatoid, Asthma, Atrial Fibrillation, Mental Disorders, Cardiovascular Diseases, Coronary Disease, Dementia, Depression, Diabetes Mellitus, Epilepsy, Heart Failure, Hypertension, Lung Neoplasms, Neoplasms, Obesity, Prostatic Neoplasms, Pulmonary Disease, Chronic Obstructive, Renal Insufficiency, Chronic, Peripheral Arterial Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡